Related Experiment Video

Updated: May 16, 2026

Yeast As a Chassis for Developing Functional Assays to Study Human P53
14:57

Yeast As a Chassis for Developing Functional Assays to Study Human P53

Published on: August 4, 2019

p53, SKP2, and DKK3 as MYCN Target Genes and Their Potential Therapeutic Significance

Lindi Chen1, Deborah A Tweddle

  • 1Newcastle Cancer Centre, Northern Institute for Cancer Research, Newcastle University Newcastle, UK.

Frontiers in Oncology
|December 11, 2012
PubMed

Insights

Neuroblastoma, a challenging childhood cancer, has poor survival rates, especially for high-risk patients. Targeting MYCN-regulated genes like p53, SKP2, and DKK3 may offer new therapeutic strategies to improve outcomes.

Area of Science:

  • Pediatric Oncology
  • Cancer Genetics
  • Molecular Biology

Background:

  • Neuroblastoma is the most common pediatric extracranial solid tumor.
  • High-risk neuroblastoma has a poor prognosis, with less than 40% long-term survival.
  • The MYCN proto-oncogene is crucial in neuroblastoma development and progression.

Purpose of the Study:

  • To review genes regulated by MYCN in neuroblastoma.
  • To highlight the roles of p53, SKP2, and DKK3 in MYCN-driven neuroblastoma.
  • To discuss potential therapeutic strategies targeting these genes.

Main Methods:

  • Literature review of MYCN-regulated genes in neuroblastoma.
  • Analysis of the roles of p53, SKP2, and DKK3 in tumor progression.
  • Exploration of therapeutic targeting strategies.

Main Results:

  • MYCN amplification is linked to aggressive tumor behavior and poor prognosis.
  • Specific genes, including p53, SKP2, and DKK3, are significantly influenced by MYCN.
  • Understanding these gene interactions is key to developing novel treatments.

Conclusions:

  • Targeting MYCN-regulated pathways presents a promising avenue for improving neuroblastoma treatment.
  • Further research into p53, SKP2, and DKK3 could lead to more effective and less toxic therapies.
  • Novel therapeutic strategies are urgently needed to improve survival rates for high-risk neuroblastoma patients.
Keywords:
DKK3MDM2-p53 antagonistsMYCNSKP2neuroblastomap53

More Related Videos

Analysis of Combinatorial miRNA Treatments to Regulate Cell Cycle and Angiogenesis11:44

Analysis of Combinatorial miRNA Treatments to Regulate Cell Cycle and Angiogenesis

Published on: March 30, 2019

Characterization of Functionally Associated miRNAs in Glioblastoma and their Engineering into Artificial Clusters for Gene Therapy09:40

Characterization of Functionally Associated miRNAs in Glioblastoma and their Engineering into Artificial Clusters for Gene Therapy

Published on: October 4, 2019

Related Concept Videos

Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
Induced Pluripotent Stem Cells01:06

Induced Pluripotent Stem Cells

Stem cells are undifferentiated cells that divide and produce different cell types. Ordinarily, cells that have differentiated into a specific cell type are terminally differentiated; however, scientists have found a way to reprogram these mature cells so that they dedifferentiate and return to an unspecialized, proliferative state. These cells are pluripotent like embryonic stem cells—able to produce all cell types—and are called induced pluripotent stem cells (iPSCs).
Somatic cells are...
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...